← Back to patent-cliff list
HW-N2001
Tier C — Watch / tradeHW-N2001
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：Peptic ulcer bleeding, Gastro-oesophageal reflux disease, 胃肠道出血
Regional status
US
-
EU
-
China
Phase III
2026-01-16
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of HW-N2001?
Approved indications include: Peptic ulcer bleeding, Gastro-oesophageal reflux disease, 胃肠道出血.
When does the HW-N2001 patent expire?
No public expiry year is available for HW-N2001 yet; this page updates once verified.
How do I get a quote for HW-N2001 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29